Hyperglycemia down-regulates apolipoprotein M expression in vivo and in vitro

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1771, Issue 7, 2007, Pages 879-882

  Zhang, Xiaoying ^a   Jiang, Bo ^a   Luo, Guanghua ^a   Nilsson Ehle, Peter ^b   Xu, Ning ^b  

^a SOOCHOW UNIVERSITY   (China)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Apolipoprotein M; Diabetes; Glucose; Hyperglycemia; Insulin

Indexed keywords

ALLOXAN; APOLIPOPROTEIN B; APOLIPOPROTEIN M; COMPLEMENTARY DNA; GLUCOSE; INSULIN; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIABETES MELLITUS; DISEASE MODEL; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; LIVER CELL CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; APOLIPOPROTEINS; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GLUCOSE; HUMANS; HYPERGLYCEMIA; INSULIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

MUS; RATTUS;

EID: 34249984497     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2007.04.020     Document Type: Article

References (11)

1. Xu N., and Dahlback B. A novel human apolipoprotein (apoM). J. Biol. Chem. 274 (1999) 31286-31290
2. Zhang X.Y., Dong X., Zheng L., Luo G.H., Liu Y.H., Ekstrom U., Nilsson-Ehle P., Ye Q., and Xu N. Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization. Acta Histochem. 105 (2003) 67-72
3. Wolfrum C., Poy M.N., and Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat. Med. 11 (2005) 418-422
4. Xu N., Nilsson-Ehle P., and Ahren B. Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects. J. Nutr. Biochem. 15 (2004) 579-582
5. Xu N., Nilsson-Ehle P., and Ahren B. Suppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse: Partial reversal by insulin. Biochem. Biophys. Res. Commun. 342 (2006) 1174-1177
6. Richter S., Shih D.Q., Pearson E.R., Wolfrum C., Fajans S.S., Hattersley A.T., and Stoffel M. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels. Diabetes 52 (2003) 2989-2995
7. Xu N., Ahren B., Jiang J., and Nilsson-Ehle P. Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells. Biochim. Biophys. Acta 1761 (2006) 256-260
8. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
9. Xu N., Hurtig M., Zhang X.Y., Ye Q., and Nilsson-Ehle P. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells. Biochim. Biophys. Acta 1683 (2004) 33-37
10. Xu N., Nilsson-Ehle P., Hurtig M., and Ahren B. Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo. Biochem. Biophys. Res. Commun. 321 (2004) 916-921
11. Luo G., Hurtig M., Zhang X., Nilsson-Ehle P., and Xu N. Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells. Biochim. Biophys. Acta 1734 (2005) 198-202